Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Diet Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 11 Prostatic Neoplasms 10 Obesity 7 Colorectal Neoplasms 6 Polycystic Ovary Syndrome 4 Ovarian Neoplasms 4 Motor Activity 4 Malnutrition 4 Uterine Cervical Neoplasms 3 Radiation Injuries 3 Pancreatic Neoplasms 3 Overweight 3 Melanoma 3 Weight Loss 2 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Sarcoma 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Multiple Myeloma 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Insulin Resistance 2 Head and Neck Neoplasms 2 Glioblastoma 2 Gastrointestinal Neoplasms 2 Fatigue 2

Interventions

pembrolizumab 150 Gemcitabine 135 Paclitaxel 128 Carboplatin 118 Bevacizumab 110 Surveys and Questionnaires 97 Docetaxel 95 Cisplatin 94 Cyclophosphamide 93 Exercise 89 Blood Specimen Collection 85 Nivolumab 82 Fluorouracil 75 Capecitabine 73 Dexamethasone 70 Radiotherapy 69 Irinotecan 62 Standard of Care 59 Pemetrexed 59 Oxaliplatin 57 Leucovorin 54 Drug Therapy 54 Cetuximab 48 Erlotinib Hydrochloride 46 atezolizumab 44 Sorafenib 44 Interviews as Topic 41 Doxorubicin 41 Ipilimumab 38 Magnetic Resonance Spectroscopy 37

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05441163 2025-06-24

ProActIF-01

Institut Curie

Phase NA Recruiting

Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡